Research Topic

New Insights into Fibrotic Signaling in Cancer

About this Research Topic

Cancer is still a top leading cause of death worldwide. Ineffective treatments, severe side effects, drug resistance, recurrence, and metastasis are major barriers to curing cancers. Latest therapies targeting tumor microenvironment show promise. Unexpectedly, limited cancer patients response to the latest PD-L1 targeted immunotherapies, and the underlying mechanism is still unclear.

In fact, cancer is catalogued as an inflammatory disease. Increasing evidence reveal the involvement of fibrotic signaling, e.g. TGF-beta and NF-kB signaling, in the cancer development. A better understanding of how pathogenic signalings from the tissue fibrosis contributing to the tumorigenesis would uncover novel pathogenic mechanisms and therapeutic targets for cancer.

This Research Topic serves as an interactive platform for sharing the latest insights of molecular mechanisms, translational potential, and clinical observations of the tumor microenvironment with advanced research strategies for cancer. Original Research, Review, Mini-Review, Clinical Trial, and Perspective articles covering the listed areas are welcome:

1) New emerging roles for fibrotic signaling in cancer development

2) Pathogenic functions of mechanisms from the tissue fibrosis in cancer

3) Novel approaches for dissecting the fibrotic signaling in cancer progression and drug resistance

4) Fibrotic signaling in cancer immunology

5) Latest therapeutic approaches for targeting the fibrotic signaling in cancer

Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.


Keywords: Fibrosis, Signaling, Drug Resistence


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Cancer is still a top leading cause of death worldwide. Ineffective treatments, severe side effects, drug resistance, recurrence, and metastasis are major barriers to curing cancers. Latest therapies targeting tumor microenvironment show promise. Unexpectedly, limited cancer patients response to the latest PD-L1 targeted immunotherapies, and the underlying mechanism is still unclear.

In fact, cancer is catalogued as an inflammatory disease. Increasing evidence reveal the involvement of fibrotic signaling, e.g. TGF-beta and NF-kB signaling, in the cancer development. A better understanding of how pathogenic signalings from the tissue fibrosis contributing to the tumorigenesis would uncover novel pathogenic mechanisms and therapeutic targets for cancer.

This Research Topic serves as an interactive platform for sharing the latest insights of molecular mechanisms, translational potential, and clinical observations of the tumor microenvironment with advanced research strategies for cancer. Original Research, Review, Mini-Review, Clinical Trial, and Perspective articles covering the listed areas are welcome:

1) New emerging roles for fibrotic signaling in cancer development

2) Pathogenic functions of mechanisms from the tissue fibrosis in cancer

3) Novel approaches for dissecting the fibrotic signaling in cancer progression and drug resistance

4) Fibrotic signaling in cancer immunology

5) Latest therapeutic approaches for targeting the fibrotic signaling in cancer

Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.


Keywords: Fibrosis, Signaling, Drug Resistence


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

06 August 2021 Abstract
04 December 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

06 August 2021 Abstract
04 December 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..